Please use this identifier to cite or link to this item: http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/3422
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTorul, D.-
dc.contributor.authorCezairli, B.-
dc.contributor.authorKahveci, K.-
dc.date.accessioned2023-01-06T10:56:27Z-
dc.date.available2023-01-06T10:56:27Z-
dc.date.issued2021-
dc.identifier.citationTorul, D., Cezairli, B., Kahveci, K. (2021). The efficacy of intra-articular injectable platelet-rich fibrin application in the management of Wilkes stage III temporomandibular joint internal derangement. International Journal of Oral and Maxillofacial Surgery, 50(11), 1485-1490.Doi:10.1016/j.ijom.2021.03.004en_US
dc.identifier.isbn0901-5027-
dc.identifier.isbn1399-0020-
dc.identifier.urihttp://dx.doi.org/10.1016/j.ijom.2021.03.004-
dc.identifier.urihttps://www.webofscience.com/wos/woscc/full-record/WOS:000729202000013-
dc.identifier.urihttps://pubmed.ncbi.nlm.nih.gov/33771436-
dc.identifier.urihttp://earsiv.odu.edu.tr:8080/xmlui/handle/11489/3422-
dc.descriptionWoS Categories : Dentistry, Oral Surgery & Medicine; Surgery Web of Science Index : Science Citation Index Expanded (SCI-EXPANDED) Research Areas : Dentistry, Oral Surgery & Medicine; Surgeryen_US
dc.description.abstractThe aim of this retrospective study was to compare the effectiveness of hyaluronic acid (HA) and injectable platelet-rich fibrin (i-PRF) in the management of Wilkes stage III internal derangement, and to evaluate the biosupplementation capacity of i-PRF. The records of all 54 relevant patients with Wilkes stage III internal derangement confirmed by magnetic resonance imaging and treated with arthrocentesis alone or in combination with HA or i-PRF were selected. The outcome variables were pain intensity at rest (VASr) and in function (VASf), evaluated with a visual analogue scale, and maximum mouth opening (MMO), evaluated in millimetres; assessments were made preoperatively, immediately after the procedure, and at 1 week, 1 month, and 3 months postoperatively. When compared to the HA and arthrocentesis groups, the i-PRF group showed significantly better improvements in MMO at 1 and 3 months (P = 0.024 and P = 0.006, respectively), VASr at 1 and 3 months (both P < 0.001), and VASf at 1 week (P = 0.019) and 1 and 3 months (both P < 0.001) postoperatively. In all groups, better MMO, VASr, and VASf values were observed compared to the preoperative status. The application of i-PRF after arthrocentesis is more effective than arthrocentesis alone or with HA in the short term. HA was found not to provide significant additional benefits over arthrocentesis alone.en_US
dc.language.isoengen_US
dc.publisherCHURCHILL LIVINGSTONE EDINBURGHen_US
dc.relation.isversionof10.1016/j.ijom.2021.03.004en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectPLUS HYALURONIC-ACID; SODIUM HYALURONATE; PLASMA INJECTION; DISC DISPLACEMENT; GROWTH-FACTORS; ARTHROCENTESIS; OSTEOARTHRITIS; ARTHROSCOPY; TENOXICAM; SUPERIORen_US
dc.subjectarthrocentesis; temporomandibular joint disorders; temporomandibular joint; degenerative; platelet-rich fibrinen_US
dc.titleThe efficacy of intra-articular injectable platelet-rich fibrin application in the management of Wilkes stage III temporomandibular joint internal derangementen_US
dc.typearticleen_US
dc.relation.journalINTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERYen_US
dc.contributor.departmentOrdu Üniversitesien_US
dc.contributor.authorID0000-0003-2323-606Xen_US
dc.contributor.authorID0000-0001-8532-3367en_US
dc.identifier.volume50en_US
dc.identifier.issue11en_US
dc.identifier.startpage1485en_US
dc.identifier.endpage1490en_US
Appears in Collections:Ağız, Diş ve Çene Cerrahisi

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.